We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Laboratory Corporation of America Holdings | NYSE:LH | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.07 | 0.53% | 201.32 | 202.92 | 199.68 | 201.12 | 554,921 | 01:00:00 |
By Michael Dabaie
Walgreens said it entered into an agreement with Laboratory Corp. of America Holdings to sell Pixel by Labcorp Covid-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores beginning in the spring.
Walgreens said the deal is part of its efforts to increase access to Covid-19 testing in communities across the U.S.
This kit will be Walgreens's first over-the-counter COVID-19 testing option available for purchase in-store and is aimed to address stores that don't currently have testing available on-site, the company said.
Customers will be able to purchase the kit at the pharmacy counter without a prescription at up to 6,000 Walgreens stores nationwide. Customers can self-administer the test collection using a short nasal swab and send their sample back to Labcorp via pre-paid FedEx Express Overnight. Once processed by Labcorp, test results are accessed by the customer via the Pixel by Labcorp website.
If a Covid-19 test is positive, a Labcorp-verified healthcare staff member will contact individuals directly by phone or mail to discuss next steps. Pixel by Labcorp has contracted with a physician network to provide independent physician services for consultation.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
February 24, 2021 13:44 ET (18:44 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Laboratory Corporation o... Chart |
1 Month Laboratory Corporation o... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions